Targeting Glutaminase1 and Synergizing With Clinical Drugs Achieved More Promising Antitumor Activity on Multiple Myeloma

Oncotarget - United States
doi 10.18632/oncotarget.27243
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

Impact Journals, LLC

Related search

GPRC5D CAR T-Cell Therapy Has Antitumor Activity in Multiple Myeloma

Cancer Discovery
Oncology
2019English

Clinical Implications of Targeting XPO1-Mediated Nuclear Export in Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

Chimeric Antigen Receptor T Cell Targeting B Cell Maturation Antigen Immunotherapy Is Promising for Multiple Myeloma

Annals of Hematology
MedicineHematology
2019English

Targeting the Pim Kinases in Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2015English

Correction: Toosendanin Demonstrates Promising Antitumor Efficacy in Osteosarcoma by Targeting STAT3

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

A Rare Case of Multiple Myeloma With Intracranial Extramedullary Relapse: One or More Myeloma Clones?

Clinical Case Reports
Medicine
2019English

Novel Drugs for the Treatment of Multiple Myeloma

Haematologica
Hematology
2010English

Hypodiploid Multiple Myeloma Is Characterized by More Aggressive Molecular Markers Than Non-Hyperdiploid Multiple Myeloma

Haematologica
Hematology
2013English

Generation of Potent Antitumor CTL From Patients With Multiple Myeloma Directed Against HM1.24

Clinical Cancer Research
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy